Oncology Views & Analysis

Views & Analysis

Oncology

Lung cancer lung disease 3d illustration

Innovation, real-world data, and precision medicine: Pierre ...

Ahead of ASCO 2025, Pierre Fabre charts bold progress in NSCLC with targeted therapies, real-world data, and innovative partnerships

Oncology

AACR 2025: New modalities and remaining challenges

Explore the latest advancements and challenges in ADC therapy at AACR 2025: New modalities and remaining challenges

Spotlight on

ESMO 2025

Spotlight On: ESMO 2025 collates pharmaphorum's coverage of the Congress, including expert insights and interviews.

Spotlight on

As the buzz increases in volume and the clock to kick-off counts down, keep an eye on this Spotlight On page for content coming to you from onsite in Chicago. We’ll have features and video content rolling out as the presentations unfold day by day.

Oncology

The mesenchymal stem cell’s superpower: Hacking the TME

What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) could disrupt this shield.

Oncology

consultants discuss treatment options with prostate cancer patient

Prostate cancer: HCPs discuss emerging treatments, artificia...

In March, the UK marked Prostate Cancer Awareness Month - a period dedicated to boosting recognition and tackling stigma of a cancer that affects approximately one in eight men nationwide.<

Innovation, real-world data, and precision medicine: Pierre ...

AACR 2025: New modalities and remaining challenges

ESMO 2025

ASCO 2025

The mesenchymal stem cell’s superpower: Hacking the TME

Prostate cancer: HCPs discuss emerging treatments, artificia...

Praxis soars on rare childhood epilepsy trial data

How to meet your physicians where they are online

Views & Analysis

Editor's Picks